Search filters

List of works by Kim Kramer

A case of mannitol hypersensitivity

scientific article

A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapy.

scientific article

A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors

scientific article

A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors

scientific article

A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastoma

scientific article published on 20 September 2016

A phase II study of radioimmunotherapy with intraventricular 131 I-3F8 for medulloblastoma.

scientific article

A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignancies

scientific article published in September 2007

Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study

scientific article published on 10 May 2018

Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age

scientific article published on 01 September 1998

Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan: A Phase I study in patients with chemoresistant neuroblastoma

scientific article

Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study

scientific article

Assessing Cerebrospinal Fluid Flow Dynamics in Pediatric Patients with Central Nervous System Tumors Treated with Intraventricular Radioimmunotherapy

scientific article published on 31 January 2020

Autologous bone marrow transplantation in children with advanced neuroblastoma

scientific article published on 01 October 1995

Biodistribution and Dosimetry of Intraventricularly Administered 124I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors

scientific article published on 12 August 2019

Brain-sparing radiotherapy for neuroblastoma skull metastases

scientific article published on 01 June 2008

CMET-28. IMPACT OF DISEASE SITE, SIZE AND SURGICAL RESECTION ON SURVIVAL FROM METASTATIC CNS NEUROBLASTOMA

Camptothecin analogs (irinotecan or topotecan) plus high-dose cyclophosphamide as preparative regimens for antibody-based immunotherapy in resistant neuroblastoma

scientific article

Central nervous system neuroblastoma metastases pseudoprogression following intraventricular anti-B7-H3 radioimmunotherapy

scientific article published on 16 July 2019

Central nervous system relapse of rhabdomyosarcoma

scientific article

Chronic neuroblastoma

scientific article published in September 2002

Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p.

scientific article

Clinically critical impact of molecular genetic studies in pediatric solid tumors

scientific article published on 01 December 1999

Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma

scientific article

Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial.

scientific article

Correlation of MYCN amplification, Trk-A and CD44 expression with clinical stage in 250 patients with neuroblastoma ⬇️

scientific article published on 01 October 1997

Curability of recurrent disseminated disease after surgery alone for local-regional neuroblastoma using intensive chemotherapy and anti-G(D2) immunotherapy

scientific article published in July 2003

DIPG-16. DELAYED RT IN SELECT PATIENTS WITH DIPG

scientific article published on 22 June 2018

DIPG-22. A PHASE 1 TRIAL OF THE HISTONE DEACETYLASE INHIBITOR PANOBINOSTAT IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY DIFFUSE INTRINSIC PONTINE GLIOMA: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY

Detection of neuroblastoma in bone marrow by immunocytology: is a single marrow aspirate adequate?

scientific article published on 01 February 1999

Differential impact of high-dose cyclophosphamide, topotecan, and vincristine in clinical subsets of patients with chemoresistant neuroblastoma

scientific article published in June 2010

Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma.

scientific article

Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma ⬇️

scientific article published on September 1, 1998

EMBR-03. TREATMENT OF EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES (ETMR) WITH TARGETED RADIOIMMUNOTHERAPY

EPEN-04. RECURRENT EPENDYMOMA: ROLE OF INTRAVENTRICULAR TARGETED RADIOIMMUNOTHERAPY

EPT-08A PHASE I STUDY OF SINGLE-AGENT PERIFOSINE FOR RECURRENT/REFRACTORY PEDIATRIC CNS AND SOLID TUMORS.

scientific article published on 30 May 2016

Establishing successful cerebrospinal fluid flow for radioimmunotherapy

scientific article published in March 2012

Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients

scientific article published in July 2001

Extracellular vesicle and particle biomarkers define multiple human cancers

journal article published in 2020

Favorable-biology neuroblastoma presenting with leptomeningeal metastases?: a case presentation

scientific article published on 01 November 2004

Five-day courses of irinotecan as palliative therapy for patients with neuroblastoma.

scientific article

Granulocyte-colony stimulating factor and multiple cycles of strongly myelosuppressive alkylator-based combination chemotherapy in children with neuroblastoma

scientific article

High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors ⬇️

scientific article published on September 1, 1998

High-dose carboplatin-irinotecan-temozolomide: treatment option for neuroblastoma resistant to topotecan

scientific article

High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy

scientific article published in April 2007

High-dose cyclophosphamide-irinotecan-vincristine for primary refractory neuroblastoma

scientific article published on 08 October 2010

Hyperfractionated low-dose (21 Gy) radiotherapy for cranial skeletal metastases in patients with high-risk neuroblastoma.

scientific article published on 8 May 2009

Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery

scientific article

Hypothyroidism after 131I-monoclonal antibody treatment of neuroblastoma

scientific article published in July 2010

IMMU-05. SAFETY AND EFFICACY OF INTRAVENTRICULAR I-LABELED MONOCLONAL ANTIBODY 8H9 TARGETING THE SURFACE GLYCOPROTEIN B7-H3

IMMU-10. CENTRAL NERVOUS SYSTEM NEUROBLASTOMA METASTASES PSEUDOPROGRESSION FOLLOWING INTRAVENTRICULAR ANTI-B7H3 RADIOIMMUNOTHERAPY

scientific article published on 23 April 2019

Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literature

scientific article published on 05 September 2012

Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy.

scientific article published in March 2003

IntraOmmaya compartmental radioimmunotherapy using 131I-omburtamab-pharmacokinetic modeling to optimize therapeutic index

scientific article published on 13 October 2020

Irinotecan plus temozolomide for relapsed or refractory neuroblastoma.

scientific article

Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma

scientific article

Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin

scientific article published on 26 November 2015

Large congenital melanotic nevi in an extremity with neurocutaneous melanocytosis

scientific article published in January 2009

Liver involvement in neuroblastoma: the Memorial Sloan-Kettering Experience supports treatment reduction in young patients

scientific article published on 01 March 2006

Long-term complications in survivors of advanced stage neuroblastoma

scientific article published in September 2005

Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapy

scientific article published on 06 May 2015

MEDU-04. A PHASE II STUDY OF RADIOIMMUNOTHERAPY WITH INTRAVENTRICULAR 131I-3F8 FOR MEDULLOBLASTOMA.

scientific article

METB-05. NON-INVASIVE DIAGNOSIS OF BRAINSTEM GLIOMAS IN PEDIATRIC, ADOLESCENT, AND YOUNG ADULT PATIENTS THROUGH CEREBROSPINAL FLUID CELL-FREE DNA SEQUENCING

scientific article published in 2023

MYCN-amplified stage 2/3 neuroblastoma: excellent survival in the era of anti-GD2 immunotherapy.

scientific article published on 24 August 2017

Management and outcome of stage 3 neuroblastoma

scientific article

Marker (+) CNS germ cell tumors in remission: are surveillance MRI scans necessary?

scientific article

Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors

scientific article

Monoclonal antibody to human trk-A: diagnostic and therapeutic potential in neuroblastoma ⬇️

scientific article published on 01 October 1997

Monoclonal antibody-based therapy of neuroblastoma

scientific article

Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission

scientific article

N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.

scientific article published in January 2001

NIMG-42. INCIDENCE OF CAVERNOMATOUS LESIONS ON BRAIN MR OF PEDIATRIC PATIENTS TREATED WITH INTRAVENTRICULAR RADIOIMMUNOTHERAPY

NSRG-11. DIVERSION OF CSF WITH PROGRAMMABLE VENTRICULOPERITONEAL SHUNTS: ROLE WITH INTRAVENTRICULAR RADIOIMMUNOTHERAPY

Neuroblastoma and treatment-related myelodysplasia/leukemia: the Memorial Sloan-Kettering experience and a literature review

scientific article published on 01 December 1998

Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experience

scientific article published in December 2003

Neuroblastoma metastatic to the central nervous system. The Memorial Sloan-kettering Cancer Center Experience and A Literature Review

scientific article

Oral etoposide for refractory and relapsed neuroblastoma.

scientific article

Oral topotecan for refractory and relapsed neuroblastoma: a retrospective analysis

scientific article published in August 2003

Osteochondroma in long-term survivors of high-risk neuroblastoma

scientific article published on 27 February 2015

Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma

scientific article published in July 2006

PDCT-04. SAFETY AND EFFICACY OF INTRAVENTRICULAR I-LABELED MONOCLONAL ANTIBODY 8H9 TARGETING THE SURFACE GLYCOPROTEIN B7-H3 IN PATIENTS WITH CNS/LM DISEASE

scientific article published on 06 November 2017

Pharmacokinetics and acute toxicology of intraventricular 131 I-monoclonal antibody targeting disialoganglioside in non-human primates

scientific article published on November 1, 1997

Pharmacokinetics, dosimetry, and toxicity of the targetable atomic generator, 225Ac-HuM195, in nonhuman primates

scientific article

Phase I study of targeted radioimmunotherapy for leptomeningeal cancers using intra-Ommaya 131-I-3F8.

scientific article

Phase I trial of a bivalent gangliosides vaccine in combination with β-glucan for high-risk neuroblastoma in second or later remission

scientific article published on 11 February 2014

Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma

scientific article published on 01 November 2001

Pilot study of topotecan and high-dose cyclophosphamide for resistant pediatric solid tumors.

scientific article published in November 2000

Plerixafor plus granulocyte-colony stimulating factor for autologous hematopoietic stem cell mobilization in patients with metastatic neuroblastoma

scientific article published on 17 March 2011

Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody

scientific article

Preliminary results of a phase I trial of prophylactic ethanol-lock administration to prevent mediport catheter-related bloodstream infections

scientific article published on October 2010

Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma

scientific article published in August 1996

Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-GD2 immunotherapy and isotretinoin: a prospective Phase II study

scientific article published on 22 May 2015

Quantitation of GD2 synthase mRNA by real-time reverse transcriptase polymerase chain reaction: clinical utility in evaluating adjuvant therapy in neuroblastoma

scientific article published on 01 March 2003

RONC-06. INCIDENCE OF CAVERNOMATOUS LESIONS ON BRAIN MR OF PEDIATRIC PATIENTS TREATED WITH INTRAVENTRICULAR RADIOIMMUNOTHERAPY

Radically different treatment recommendations for newly diagnosed neuroblastoma: pitfalls in assessment of risk.

scientific article published in January 2004

Recurrent metastatic neuroblastoma followed by myelodysplastic syndrome: possible leukemogenic role of temozolomide

scientific article

Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma

scientific article

Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma

scientific article published on 01 July 2020

Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma

scientific article

Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group

scientific article published on 01 June 2020

SCDT-38. SAFETY AND EFFICACY OF INTRAVENTRICULAR I-LABELED MONOCLONAL ANTIBODY 8H9 TARGETING THE SURFACE GLYCOPROTEIN B7-H3 IN PATIENTS WITH CNS/LM DISEASE

scientific article published on 06 November 2017

Safety profile of long-term intraventricular access devices in pediatric patients receiving radioimmunotherapy for central nervous system malignancies

scientific article published on 29 April 2014

Sensitivity of surveillance studies for detecting asymptomatic and unsuspected relapse of high-risk neuroblastoma.

scientific article published on 26 January 2009

Solitary relapse of desmoplastic small round cell tumor detected by positron emission tomography/computed tomography

scientific article published on 22 September 2008

Striking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary era.

scientific article

Successful multifold dose escalation of anti-GD2 monoclonal antibody 3F8 in patients with neuroblastoma: a phase I study.

scientific article

Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers ⬇️

scientific article published on October 1, 1997

Synovial sarcoma mimicking desmoplastic small round-cell tumor: critical role for molecular diagnosis

scientific article published on 01 February 1999

THER-24. TARGETED RADIOIMMUNOTHERAPY FOR EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES

scientific article published on 23 April 2019

THER-27. ASSESSING CEREBROSPINAL FLUID FLOW IN PEDIATRIC PATIENTS WITH CENTRAL NERVOUS SYSTEM TUMORS TREATED WITH INTRAVENTRICULAR RADIOIMMUNOTHERAPY

scientific article published on 23 April 2019

Targeted radioimmunotherapy for embryonal tumor with multilayered rosettes

scientific article published on 16 March 2019

Targeted radioimmunotherapy for leptomeningeal cancer using (131)I-3F8.

scientific article published on December 2000

The impact of gross total resection on local control and survival in high-risk neuroblastoma

scientific article published on March 2004

Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults

scientific article

Transient sialoadenitis: a complication of 131I-metaiodobenzylguanidine therapy

scientific article published in June 2008

Treatment and outcome of adult-onset neuroblastoma.

scientific article published on 25 March 2018

Treatment of neuroblastoma meningeal carcinomatosis with intrathecal application of alpha-emitting atomic nanogenerators targeting disialo-ganglioside GD2.

scientific article

Treatment of spinal involvement in neuroblastoma patients.

scientific article published on December 2003

Two-compartment model of radioimmunotherapy delivered through cerebrospinal fluid ⬇️

scientific article published on October 9, 2010

When overall survival fails to confirm event-free survival, should the latter be used to set the standard of care?

scientific article published on 17 November 2014

Whole neuraxis irradiation to address central nervous system relapse in high-risk neuroblastoma

scientific article published on 6 March 2010

Paulina is supported by:

About Paulina

Help